X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare FDC LTD. with Glenmark Pharma - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

FDC LTD. vs GLENMARK PHARMA - Comparison Results

GLENMARK PHARMA 
   Change

Glenmark's focus areas are dermatology, gynecology, pediatrics and diabetics. The domestic formulations business contributed about 35% to revenues in FY07. On the international front, besides exports to the semi-regulated markets, the company has bee... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    FDC LTD. GLENMARK PHARMA FDC LTD./
GLENMARK PHARMA
 
P/E (TTM) x 22.2 25.3 87.9% View Chart
P/BV x 5.0 4.0 126.3% View Chart
Dividend Yield % 0.9 0.3 310.4%  

Financials

 FDC LTD.   GLENMARK PHARMA
EQUITY SHARE DATA
    FDC LTD.
Mar-14
GLENMARK PHARMA
Mar-17
FDC LTD./
GLENMARK PHARMA
5-Yr Chart
Click to enlarge
High Rs144993 14.5%   
Low Rs79729 10.8%   
Sales per share (Unadj.) Rs47.6325.5 14.6%  
Earnings per share (Unadj.) Rs7.639.3 19.4%  
Cash flow per share (Unadj.) Rs9.048.7 18.5%  
Dividends per share (Unadj.) Rs2.252.00 112.5%  
Dividend yield (eoy) %2.00.2 870.8%  
Book value per share (Unadj.) Rs47.5159.2 29.9%  
Shares outstanding (eoy) m177.83282.17 63.0%   
Bonus/Rights/Conversions BBESOP-  
Price / Sales ratio x2.32.6 88.4%   
Avg P/E ratio x14.621.9 66.7%  
P/CF ratio (eoy) x12.317.7 69.8%  
Price / Book Value ratio x2.35.4 43.3%  
Dividend payout %29.65.1 580.9%   
Avg Mkt Cap Rs m19,784242,991 8.1%   
No. of employees `000NA13.0 0.0%   
Total wages/salary Rs m1,22116,408 7.4%   
Avg. sales/employee Rs ThNM7,083.9-  
Avg. wages/employee Rs ThNM1,265.4-  
Avg. net profit/employee Rs ThNM855.1-  
INCOME DATA
Net Sales Rs m8,45991,857 9.2%  
Other income Rs m394374 105.3%   
Total revenues Rs m8,85292,230 9.6%   
Gross profit Rs m2,07020,367 10.2%  
Depreciation Rs m2492,644 9.4%   
Interest Rs m312,373 1.3%   
Profit before tax Rs m2,18415,724 13.9%   
Minority Interest Rs m00-   
Prior Period Items Rs m-2250-   
Extraordinary Inc (Exp) Rs m0-810 0.0%   
Tax Rs m6063,827 15.8%   
Profit after tax Rs m1,35311,088 12.2%  
Gross profit margin %24.522.2 110.4%  
Effective tax rate %27.724.3 113.9%   
Net profit margin %16.012.1 132.5%  
BALANCE SHEET DATA
Current assets Rs m4,35568,746 6.3%   
Current liabilities Rs m1,79227,027 6.6%   
Net working cap to sales %30.345.4 66.7%  
Current ratio x2.42.5 95.6%  
Inventory Days Days4485 52.3%  
Debtors Days Days2596 25.8%  
Net fixed assets Rs m3,02524,132 12.5%   
Share capital Rs m179282 63.3%   
"Free" reserves Rs m8,24344,643 18.5%   
Net worth Rs m8,45344,925 18.8%   
Long term debt Rs m1145,363 0.0%   
Total assets Rs m10,557117,639 9.0%  
Interest coverage x71.47.6 936.5%   
Debt to equity ratio x01.0 0.1%  
Sales to assets ratio x0.80.8 102.6%   
Return on assets %13.111.4 114.6%  
Return on equity %16.024.7 64.9%  
Return on capital %23.519.1 122.8%  
Exports to sales %13.30-   
Imports to sales %3.30-   
Exports (fob) Rs m1,126NA-   
Imports (cif) Rs m283NA-   
Fx inflow Rs m1,14656,152 2.0%   
Fx outflow Rs m3558,084 4.4%   
Net fx Rs m79148,068 1.6%   
CASH FLOW
From Operations Rs m1,4856,574 22.6%  
From Investments Rs m-620-7,124 8.7%  
From Financial Activity Rs m-7535,432 -13.9%  
Net Cashflow Rs m1131,992 5.7%  

Share Holding

Indian Promoters % 68.9 48.3 142.7%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 4.7 6.9 68.1%  
FIIs % 7.5 34.4 21.8%  
ADR/GDR % 0.0 0.0 -  
Free float % 19.0 10.5 181.0%  
Shareholders   23,730 56,727 41.8%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare FDC LTD. With:   ALEMBIC PHARMA  FRESENIUS KABI ONCO.  TTK HEALTHCARE  ASTRAZENECA PHARMA  DISHMAN PHARMA  

Compare FDC LTD. With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Slumps Over 275 Points; Realty and Banking Stocks Witness Selling(Closing)

After trading on a volatile note throughout the day, share markets in India witnessed selling pressure during the closing hours and ended the day in red.

Related Views on News

GLENMARK PHARMA Announces Quarterly Results (1QFY19); Net Profit Down 30.1% (Quarterly Result Update)

Aug 13, 2018 | Updated on Aug 13, 2018

For the quarter ended June 2018, GLENMARK PHARMA has posted a net profit of Rs 2 bn (down 30.1% YoY). Sales on the other hand came in at Rs 22 bn (down 8.4% YoY). Read on for a complete analysis of GLENMARK PHARMA's quarterly results.

FDC LTD. Announces Quarterly Results (1QFY19); Net Profit Up 74.5% (Quarterly Result Update)

Aug 6, 2018 | Updated on Aug 6, 2018

For the quarter ended June 2018, FDC LTD. has posted a net profit of Rs 511 m (up 74.5% YoY). Sales on the other hand came in at Rs 3 bn (up 16.7% YoY). Read on for a complete analysis of FDC LTD.'s quarterly results.

Glenmark: Most Geographies Show Weak Growth (Quarterly Results Update - Detailed)

Nov 7, 2017

Poor show in the US, Latam and India hit profits during the quarter.

Glenmark: Zetia Bolsters Sales and Profits (Quarterly Results Update - Detailed)

Oct 30, 2017

The 180-day exclusivity for Zetia enabled Glenmark to show strong growth in sales and profits during the quarter.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

More Views on News

Most Popular

Is It the Right Time to Buy Pharma Stocks Now?(The 5 Minute Wrapup)

Sep 12, 2018

Is the pharma sector poised for a comeback? Is the worst over? I believe so.

Want Bigger Returns Than You Thought Possible? This is Where You Should Look(Profit Hunter)

Sep 12, 2018

Richa has discovered the single most profitable opportunity in the market - read on to discover more...

Investors Are Redeeming From Equity Mutual Funds Now. Should You?(Outside View)

Sep 12, 2018

PersonalFN elucidates if you should redeem from equity mutual fund now, and the approach to follow before you decide to sell mutual funds.

Are You Blindly Investing In Equities? Read This...(Outside View)

Sep 11, 2018

PersonalFN explains how blindly investing in equities can prove hazardous to your wealth and health.

Outperformance of Strong Established Brands in the Indian Stock market(Chart Of The Day)

Sep 14, 2018

Strong Well established Indian Brands have comfortably outperformed the index in the decade post the global financial crisis.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

FDC LTD. SHARE PRICE


Sep 21, 2018 (Close)

TRACK FDC LTD.

  • Track your investment in FDC LTD. with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

COMPARE FDC LTD. WITH

MARKET STATS